In lung cancer, a protumorigenic role for RSPOs has been proposed as enhanced expression of RSPO ligands was observed in a subset of lung cancer cases, and enhanced RSPO3 expression was associated with reduced patient survival [116, 140]. The gene discussed is RSPO1; the disease is lung cancer.